# Willis Lease Finance Corp: financial statements, quarterly

WLFC · Nasdaq · CIK 1018164 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wlfc.md) · [Financials](/companies/wlfc/financials.md) · [Filings](/companies/wlfc/filings.md) · [Insiders](/companies/wlfc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wlfc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [106](/filings/0001018164-24-000089.md) | [114 d](/filings/0001018164-25-000027.md) | [119](/filings/0001018164-25-000060.md) | [151](/filings/0001018164-25-000108.md) | [146](/filings/0001018164-25-000134.md) | [153 d](/filings/0001018164-26-000041.md) | [158](/filings/0001018164-26-000053.md) | [196](/filings/0001018164-26-000068.md) | [183](/filings/0001018164-25-000134.md) | [194 d](/filings/0001018164-26-000041.md) | [194](/filings/0001018164-26-000053.md) | [194](/filings/0001018164-26-000068.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [20.0](/filings/0001018164-24-000089.md) | [16.8 d](/filings/0001018164-25-000027.md) | [27.2](/filings/0001018164-25-000060.md) | [54.1](/filings/0001018164-25-000108.md) | [33.7](/filings/0001018164-25-000134.md) | [29.4 d](/filings/0001018164-26-000041.md) | [23.9](/filings/0001018164-26-000053.md) | [28.3](/filings/0001018164-26-000068.md) | [38.0](/filings/0001018164-25-000134.md) | [14.1 d](/filings/0001018164-26-000041.md) | [33.8](/filings/0001018164-26-000053.md) | [34.0](/filings/0001018164-26-000068.md) |
| Interest expense | $m | [19.1](/filings/0001018164-24-000089.md) | [22.3 d](/filings/0001018164-25-000027.md) | [23.0](/filings/0001018164-25-000060.md) | [24.6](/filings/0001018164-25-000108.md) | [27.8](/filings/0001018164-25-000134.md) | [29.4 d](/filings/0001018164-26-000041.md) | [32.1](/filings/0001018164-26-000053.md) | [33.6](/filings/0001018164-26-000068.md) | [34.2](/filings/0001018164-25-000134.md) | [32.2 d](/filings/0001018164-26-000041.md) | [32.6](/filings/0001018164-26-000053.md) | [29.7](/filings/0001018164-26-000068.md) |
| Income tax | $m | [5.7](/filings/0001018164-24-000089.md) | [10.0 d](/filings/0001018164-25-000027.md) | [9.0](/filings/0001018164-25-000060.md) | [15.3](/filings/0001018164-25-000108.md) | [10.4](/filings/0001018164-25-000134.md) | [9.3 d](/filings/0001018164-26-000041.md) | [8.4](/filings/0001018164-26-000053.md) | [13.9](/filings/0001018164-26-000068.md) | [18.9](/filings/0001018164-25-000134.md) | [5.7 d](/filings/0001018164-26-000041.md) | [11.8](/filings/0001018164-26-000053.md) | [7.8](/filings/0001018164-26-000068.md) |
| Net income | $m | [14.6](/filings/0001018164-24-000089.md) | [11.0 d](/filings/0001018164-25-000027.md) | [20.9](/filings/0001018164-25-000060.md) | [42.6](/filings/0001018164-25-000108.md) | [24.1](/filings/0001018164-25-000134.md) | [21.1 d](/filings/0001018164-26-000041.md) | [16.9](/filings/0001018164-26-000053.md) | [60.4](/filings/0001018164-26-000068.md) | [24.3](/filings/0001018164-25-000134.md) | [12.2 d](/filings/0001018164-26-000041.md) | [25.1](/filings/0001018164-26-000053.md) | [30.2](/filings/0001018164-26-000068.md) |
| Diluted EPS | $ per share | [2.13](/filings/0001018164-24-000089.md) | not reported | [3.00](/filings/0001018164-25-000060.md) | [6.21](/filings/0001018164-25-000108.md) | [3.37](/filings/0001018164-25-000134.md) | not reported | [2.21](/filings/0001018164-26-000053.md) | [2.81](/filings/0001018164-26-000068.md) | [3.25](/filings/0001018164-25-000134.md) | not reported | [3.26](/filings/0001018164-26-000053.md) | [1.31](/filings/0001018164-26-000068.md) |
| Basic EPS | $ per share | [2.16](/filings/0001018164-24-000089.md) | not reported | [3.12](/filings/0001018164-25-000060.md) | [6.34](/filings/0001018164-25-000108.md) | [3.51](/filings/0001018164-25-000134.md) | not reported | [2.34](/filings/0001018164-26-000053.md) | [2.89](/filings/0001018164-26-000068.md) | [3.36](/filings/0001018164-25-000134.md) | not reported | [3.49](/filings/0001018164-26-000053.md) | [1.36](/filings/0001018164-26-000068.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [5.4](/filings/0001018164-23-000027.md) | [7.1](/filings/0001018164-25-000027.md) | [7.6](/filings/0001018164-24-000032.md) | [5.0](/filings/0001018164-24-000066.md) | [5.8](/filings/0001018164-24-000089.md) | [9.1](/filings/0001018164-26-000041.md) | [32.4](/filings/0001018164-25-000060.md) | [37.3](/filings/0001018164-25-000108.md) | [12.9](/filings/0001018164-25-000134.md) | [16.4](/filings/0001018164-26-000068.md) | [24.6](/filings/0001018164-26-000053.md) | [10.7](/filings/0001018164-26-000068.md) |
| Total assets | $m | [2,602](/filings/0001018164-23-000027.md) | [2,652](/filings/0001018164-25-000027.md) | [2,674](/filings/0001018164-24-000032.md) | [2,922](/filings/0001018164-24-000066.md) | [3,044](/filings/0001018164-24-000089.md) | [3,297](/filings/0001018164-26-000041.md) | [3,275](/filings/0001018164-25-000060.md) | [3,946](/filings/0001018164-25-000108.md) | [3,421](/filings/0001018164-25-000134.md) | [3,936](/filings/0001018164-26-000068.md) | [3,506](/filings/0001018164-26-000053.md) | [3,653](/filings/0001018164-26-000068.md) |
| Total liabilities | $m | [2,120](/filings/0001018164-23-000027.md) | [2,163](/filings/0001018164-25-000027.md) | [2,163](/filings/0001018164-24-000032.md) | [2,379](/filings/0001018164-24-000066.md) | [2,463](/filings/0001018164-24-000089.md) | [2,685](/filings/0001018164-26-000041.md) | [2,646](/filings/0001018164-25-000060.md) | [3,265](/filings/0001018164-25-000108.md) | [2,708](/filings/0001018164-25-000134.md) | [3,211](/filings/0001018164-26-000068.md) | [2,748](/filings/0001018164-26-000053.md) | [2,879](/filings/0001018164-26-000068.md) |
| Long-term debt | $m | [1,788](/filings/0001018164-23-000027.md) | [1,803](/filings/0001018164-25-000027.md) | [1,736](/filings/0001018164-24-000032.md) | [1,947](/filings/0001018164-24-000066.md) | [1,990](/filings/0001018164-24-000089.md) | [2,265](/filings/0001018164-26-000041.md) | [2,232](/filings/0001018164-25-000060.md) | [2,801](/filings/0001018164-25-000108.md) | [2,239](/filings/0001018164-25-000134.md) | [2,700](/filings/0001018164-26-000068.md) | [2,254](/filings/0001018164-26-000053.md) | [2,321](/filings/0001018164-26-000068.md) |
| Shareholders' equity | $m | [432](/filings/0001018164-24-000089.md) | [439](/filings/0001018164-26-000041.md) | [462](/filings/0001018164-24-000066.md) | [492](/filings/0001018164-25-000134.md) | [518](/filings/0001018164-25-000134.md) | [549](/filings/0001018164-26-000068.md) | [565](/filings/0001018164-26-000068.md) | [618](/filings/0001018164-26-000068.md) | [650](/filings/0001018164-25-000134.md) | [662](/filings/0001018164-26-000068.md) | [694](/filings/0001018164-26-000053.md) | [709](/filings/0001018164-26-000068.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [70.5 d](/filings/0001018164-24-000089.md) | [60.8 d](/filings/0001018164-25-000027.md) | [59.8](/filings/0001018164-25-000060.md) | [69.8 d](/filings/0001018164-25-000108.md) | [86.8 d](/filings/0001018164-25-000134.md) | [68.0 d](/filings/0001018164-26-000041.md) | [41.0](/filings/0001018164-26-000053.md) | [104 d](/filings/0001018164-26-000068.md) | [63.9 d](/filings/0001018164-25-000134.md) | [74.2 d](/filings/0001018164-26-000041.md) | [56.7](/filings/0001018164-26-000053.md) | [77.5 d](/filings/0001018164-26-000068.md) |
| Capital expenditure | $m | [0.7 d](/filings/0001018164-24-000089.md) | [0.9 d](/filings/0001018164-25-000027.md) | [0.4](/filings/0001018164-25-000060.md) | [1.3 d](/filings/0001018164-25-000108.md) | [1.0 d](/filings/0001018164-25-000134.md) | [12.9 d](/filings/0001018164-26-000041.md) | [7.5](/filings/0001018164-26-000053.md) | [9.6 d](/filings/0001018164-26-000068.md) | [6.0 d](/filings/0001018164-25-000134.md) | [7.9 d](/filings/0001018164-26-000041.md) | [3.5](/filings/0001018164-26-000053.md) | [2.7 d](/filings/0001018164-26-000068.md) |
| Dividends paid | $m | [0.0 d](/filings/0001018164-24-000089.md) | [0.0 d](/filings/0001018164-25-000027.md) | [0.0](/filings/0001018164-25-000060.md) | [7.1 d](/filings/0001018164-25-000108.md) | [1.8 d](/filings/0001018164-25-000134.md) | [1.8 d](/filings/0001018164-26-000041.md) | [1.8](/filings/0001018164-26-000053.md) | [1.9 d](/filings/0001018164-26-000068.md) | [1.9 d](/filings/0001018164-25-000134.md) | [3.1 d](/filings/0001018164-26-000041.md) | [3.1](/filings/0001018164-26-000053.md) | [3.0 d](/filings/0001018164-26-000068.md) |
| Share repurchases | $m | [0.0 d](/filings/0001018164-23-000027.md) | [9.4 d](/filings/0001018164-25-000027.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [6.3](/filings/0001018164-23-000027.md) | [6.5](/filings/0001018164-24-000032.md) | [6.4](/filings/0001018164-24-000066.md) | [6.5](/filings/0001018164-24-000089.md) | [6.7](/filings/0001018164-25-000060.md) | [6.7](/filings/0001018164-25-000108.md) | [6.9](/filings/0001018164-25-000134.md) | [7.0](/filings/0001018164-26-000053.md) | [21.0](/filings/0001018164-26-000068.md) | [7.0](/filings/0001018164-25-000134.md) | [7.3](/filings/0001018164-26-000053.md) | [22.0](/filings/0001018164-26-000068.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 21,144,111 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001018164-26-000068.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.